IN2012MU03359A - - Google Patents
Download PDFInfo
- Publication number
- IN2012MU03359A IN2012MU03359A IN3359MU2012A IN2012MU03359A IN 2012MU03359 A IN2012MU03359 A IN 2012MU03359A IN 3359MU2012 A IN3359MU2012 A IN 3359MU2012A IN 2012MU03359 A IN2012MU03359 A IN 2012MU03359A
- Authority
- IN
- India
- Prior art keywords
- oxo
- carboxamide
- prodrug
- thiophene
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201380068642.9A CN105431429A (zh) | 2012-12-26 | 2013-12-24 | 取代的噁唑烷酮类的醛衍生物 |
RU2015112195A RU2015112195A (ru) | 2012-12-26 | 2013-12-24 | Альдегидное производное замещенных оксазолидинонов |
EP13869179.5A EP2897619A4 (en) | 2012-12-26 | 2013-12-24 | ALDEHYDE DERIVATIVE FROM SUBSTITUTED OXAZOLIDINONES |
US14/436,018 US9359341B2 (en) | 2012-12-26 | 2013-12-24 | Aldehyde derivative of substitute oxazolidinones |
JP2015550211A JP2016504348A (ja) | 2012-12-26 | 2013-12-24 | 置換オキサゾリジノンのアルデヒド誘導体 |
IN3359MU2012 IN2012MU03359A (sl) | 2012-12-26 | 2013-12-24 | |
MX2015003319A MX2015003319A (es) | 2012-12-26 | 2013-12-24 | Derivado de aldehido de oxazolidinonas sustituidas. |
CA2883323A CA2883323A1 (en) | 2012-12-26 | 2013-12-24 | Aldehyde derivative of substituted oxazolidinones |
PCT/IN2013/000801 WO2014102822A2 (en) | 2012-12-26 | 2013-12-24 | Aldehyde derivative of substitute oxazolidinones |
BR112015011033A BR112015011033A2 (pt) | 2012-12-26 | 2013-12-24 | derivado aldeído de oxazolidinonas substituídas |
KR1020157015903A KR20150100661A (ko) | 2012-12-26 | 2013-12-24 | 치환된 옥사졸리디논의 알데히드 유도체 |
AU2013368847A AU2013368847B2 (en) | 2012-12-26 | 2013-12-24 | Aldehyde derivative of substitute oxazolidinones |
ZA2015/03700A ZA201503700B (en) | 2012-12-26 | 2015-05-25 | Aldehyde derivative of substitute oxazolidinones |
PH12015501625A PH12015501625A1 (en) | 2012-12-26 | 2015-07-22 | Aldehyde derivative of substitute oxazolidinones |
HK16105076.8A HK1217101A1 (zh) | 2012-12-26 | 2016-05-04 | 取代的噁唑烷酮類的醛衍生物 |
US15/149,998 US20160251342A1 (en) | 2012-12-26 | 2016-05-09 | Aldehyde derivative of substituted oxazolidinones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3359MU2012 IN2012MU03359A (sl) | 2012-12-26 | 2013-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012MU03359A true IN2012MU03359A (sl) | 2015-06-26 |
Family
ID=54242230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3359MU2012 IN2012MU03359A (sl) | 2012-12-26 | 2013-12-24 |
Country Status (15)
Country | Link |
---|---|
US (1) | US9359341B2 (sl) |
EP (1) | EP2897619A4 (sl) |
JP (1) | JP2016504348A (sl) |
KR (1) | KR20150100661A (sl) |
CN (1) | CN105431429A (sl) |
AU (1) | AU2013368847B2 (sl) |
BR (1) | BR112015011033A2 (sl) |
CA (1) | CA2883323A1 (sl) |
HK (1) | HK1217101A1 (sl) |
IN (1) | IN2012MU03359A (sl) |
MX (1) | MX2015003319A (sl) |
PH (1) | PH12015501625A1 (sl) |
RU (1) | RU2015112195A (sl) |
WO (1) | WO2014102822A2 (sl) |
ZA (1) | ZA201503700B (sl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2895176T (pt) | 2012-12-26 | 2017-01-27 | Wanbury Ltd | Intermediário de rivaroxabano e a sua preparação |
US20160251342A1 (en) * | 2012-12-26 | 2016-09-01 | Wanbury Ltd. | Aldehyde derivative of substituted oxazolidinones |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
DE10300111A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
DE102004002044A1 (de) | 2004-01-15 | 2005-08-04 | Bayer Healthcare Ag | Herstellverfahren |
GT200600196A (es) | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
NZ567092A (en) | 2005-10-04 | 2011-05-27 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
DE102006007146A1 (de) | 2006-02-16 | 2007-08-23 | Bayer Healthcare Ag | Aminoacyl-Prodrugs |
DE102006039589A1 (de) * | 2006-08-24 | 2008-03-06 | Bayer Healthcare Ag | Aminoacyl-Prodrugs II |
EP2190841B1 (en) | 2007-08-14 | 2013-05-15 | Concert Pharmaceuticals Inc. | Substituted oxazolidinone derivatives |
US7816355B1 (en) | 2009-04-28 | 2010-10-19 | Apotex Pharmachem Inc | Processes for the preparation of rivaroxaban and intermediates thereof |
PL2459555T3 (pl) | 2009-07-31 | 2022-03-28 | Krka, D.D., Novo Mesto | Sposoby krystalizacji rywaroksabanu |
CN102822167A (zh) | 2010-01-04 | 2012-12-12 | 埃南蒂亚有限公司 | 用于制备利伐沙班的方法及其中间体 |
EP2354128A1 (en) | 2010-02-10 | 2011-08-10 | Sandoz Ag | Method for the preparation of rivaroxaban |
CN103201260B (zh) * | 2010-11-11 | 2015-05-27 | 莱德克斯制药有限公司 | 药物衍生物 |
US9221771B2 (en) | 2011-04-11 | 2015-12-29 | Sandoz Ag | Method for the preparation of substituted oxazolidinones |
EP2705028B1 (en) | 2011-05-06 | 2019-08-21 | Egis Gyógyszergyár Zrt. | Process for the preparation of a rivaroxaban and intermediates formed in said process |
ES2395304B1 (es) | 2011-05-20 | 2014-01-16 | Interquim, S.A. | Procedimiento de obtención de una tiofen-2-carboxamida. |
PT2895176T (pt) * | 2012-12-26 | 2017-01-27 | Wanbury Ltd | Intermediário de rivaroxabano e a sua preparação |
-
2013
- 2013-12-24 WO PCT/IN2013/000801 patent/WO2014102822A2/en active Application Filing
- 2013-12-24 EP EP13869179.5A patent/EP2897619A4/en not_active Withdrawn
- 2013-12-24 RU RU2015112195A patent/RU2015112195A/ru not_active Application Discontinuation
- 2013-12-24 CA CA2883323A patent/CA2883323A1/en not_active Abandoned
- 2013-12-24 AU AU2013368847A patent/AU2013368847B2/en not_active Expired - Fee Related
- 2013-12-24 KR KR1020157015903A patent/KR20150100661A/ko not_active Application Discontinuation
- 2013-12-24 BR BR112015011033A patent/BR112015011033A2/pt not_active IP Right Cessation
- 2013-12-24 JP JP2015550211A patent/JP2016504348A/ja active Pending
- 2013-12-24 IN IN3359MU2012 patent/IN2012MU03359A/en unknown
- 2013-12-24 CN CN201380068642.9A patent/CN105431429A/zh active Pending
- 2013-12-24 US US14/436,018 patent/US9359341B2/en not_active Expired - Fee Related
- 2013-12-24 MX MX2015003319A patent/MX2015003319A/es unknown
-
2015
- 2015-05-25 ZA ZA2015/03700A patent/ZA201503700B/en unknown
- 2015-07-22 PH PH12015501625A patent/PH12015501625A1/en unknown
-
2016
- 2016-05-04 HK HK16105076.8A patent/HK1217101A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1217101A1 (zh) | 2016-12-23 |
AU2013368847A1 (en) | 2015-05-28 |
EP2897619A2 (en) | 2015-07-29 |
EP2897619A4 (en) | 2016-08-17 |
KR20150100661A (ko) | 2015-09-02 |
US20150259333A1 (en) | 2015-09-17 |
ZA201503700B (en) | 2016-10-26 |
PH12015501625A1 (en) | 2015-09-28 |
US9359341B2 (en) | 2016-06-07 |
JP2016504348A (ja) | 2016-02-12 |
CN105431429A (zh) | 2016-03-23 |
WO2014102822A2 (en) | 2014-07-03 |
WO2014102822A3 (en) | 2015-10-29 |
AU2013368847B2 (en) | 2017-03-16 |
BR112015011033A2 (pt) | 2017-07-11 |
CA2883323A1 (en) | 2014-07-03 |
RU2015112195A (ru) | 2017-01-31 |
MX2015003319A (es) | 2015-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1157759A1 (en) | New co-crystal compound of rivaroxaban and malonic acid | |
HK1130252A1 (en) | Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders | |
DK1934208T3 (da) | Ny polymorf form af 5-chlor-N-({(5S)-2-0x0-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid | |
EA201391647A1 (ru) | Способ получения ривароксабана и промежуточные соединения, получаемые в указанном способе | |
CR20150001A (es) | Formas de administración farmacéuticas que comprenden 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil) fenil]-1,3-oxazolidin-5-il}metil)-2-tiofencarboxamida | |
MX2009001977A (es) | Derivados profarmacologicos de aminoacilo y medicamentos para el tratamiento de enfermedades tromboembolicas. | |
PH12015501625A1 (en) | Aldehyde derivative of substitute oxazolidinones | |
WO2012080184A3 (de) | Flüssige, oral applizierbare pharmazeutische zusammensetzungen enthaltend 5-chlor-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid | |
IL250168A0 (en) | Crystalline form of 5 – chloro –n ( { (5s) – 2 – oxo – 3 – [ 4 – ( 5,6 – dihydro – 4h – [ 1,2,4 ] triazin-1-yl) phenyl] – 1, 3-oxazolidine-5-yl}methyl)thiophene-2-an innovative carboxamide and pharmaceutical preparations containing it | |
BR112016024825A2 (pt) | composição contendo rivaroxaban e processo para fabricação de uma composição compreendendo rivaroxaban | |
CU23445A3 (es) | Procedimiento de preparación | |
CU20080051A7 (es) | Nueva forma polimórfica y la forma amorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida |